The Recall Desk

FDA (Drugs) recall action 69152

Martin Avenue Pharmacy, Inc. recalled 118 products on 2014-11-05

The FDA (Drugs) publishes a recall like this one as 118 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 118 pages.

Products
118
Announced
2014-11-05
Critical
0
Units
40

Why these products were recalled

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

101–118 of 118

  • SevereFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Tri-mix SEST 4 Injectable Due to Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling Tri-mix SEST 4 injectable vials due to quality control observations that present a risk to sterility assurance.

    Product
    Tri-mix SEST 4, 30 mg/1.5 mg/400 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Benzalkonium Chloride Injection Vials

    Martin Avenue Pharmacy is voluntarily recalling benzalkonium chloride water for injection due to quality control issues affecting sterility assurance.

    Product
    Benzalkonium chloride water for injection packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • ModerateFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Hydroxocobalamin Injectable Due to Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling Hydroxocobalamin 10 mg/mL injectable vials due to quality control observations that present a risk to sterility assurance.

    Product
    Hydroxocobalamin 10 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Compounded Testosterone Cypionate Injection

    Martin Avenue Pharmacy is voluntarily recalling compounded Testosterone cypionate 200 mg/mL injections due to quality control observations that present a risk to sterility assurance.

    Product
    Testosterone cypionate 200 mg/mL injection packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Pilocarpine Eye Drops Due to Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling Pilocarpine 0.25% ophthalmic solution due to quality control issues that risk sterility assurance.

    Product
    Pilocarpine (PF) 0.25% opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Atropine Sulfate Eye Drops for Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling Atropine sulfate 0.5% ophthalmic solution due to quality control issues affecting sterility assurance.

    Product
    Atropine sulfate 0.5% opthalmic solution packaged in a squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Dexamethasone Sodium Phosphate Injectable Vials

    Martin Avenue Pharmacy is voluntarily recalling dexamethasone sodium phosphate injectable vials due to quality control issues that risk sterility assurance.

    Product
    Dexamethasone sodium phosphate 24 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Dexamethasone Sodium Phosphate Injectable Due to Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling Dexamethasone sodium phosphate 4 mg/mL injectable vials due to quality control observations that present a risk to sterility assurance.

    Product
    Dexamethasone sodium phosphate 4 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Compounded Sterile Preparations Due to Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including Polyhexamethylene biguanide 2% stock solution, due to quality control issues affecting sterility assurance.

    Product
    Polyhexamethylene biguanide 2% stock solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Compounded Sterile Preparations Due to Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including cyanocobalamin, due to quality control observations that risk sterility assurance.

    Product
    Cyanocobalamin 1000 mcg/mL injectable solution packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Phenol 10% Injectable Due to Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling Phenol 10% injectable vials due to quality control observations that present a risk to sterility assurance.

    Product
    Phenol 10% injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Trimethoprim/Sulfadiazine Injection Due to Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling trimethoprim/sulfadiazine excipient stock solution injections due to quality control issues that risk sterility assurance.

    Product
    Trimethoprim/sulfadiazine excipient stock solution injection packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Compounded Sterile Preparations Due to Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including Quad mix 1, due to quality control observations that present a risk to sterility assurance.

    Product
    Quad mix 1, 12 mg/1 mg/10 mcg/0.15 mg/mL (papaverine, phentolamine mesylate, alprostadil, atropine) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Cefazolin Ophthalmic Solution for Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling Cefazolin ophthalmic solution due to quality control issues that may compromise sterility.

    Product
    Cefazolin forte 25 mg/mL opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Lidocaine 1% Injectable Vials

    Martin Avenue Pharmacy is voluntarily recalling Lidocaine 1% injectable vials due to quality control observations that present a risk to sterility assurance.

    Product
    Lidocaine 1% injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Bacteriostatic Water for Injection

    Martin Avenue Pharmacy is voluntarily recalling bacteriostatic water for injection due to quality control issues affecting sterility assurance.

    Product
    Bacteriostatic water for injection packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Tri-mix Injectable Due to Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling Tri-mix T108 injectable vials due to quality control observations that present a risk to sterility assurance.

    Product
    Tri-mix T108, 30 mg/1.5 mg/25 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2014-11-05

    Martin Avenue Pharmacy Recalls Fentanyl Injectable Due to Sterility Concerns

    Martin Avenue Pharmacy is voluntarily recalling fentanyl injectable syringes due to quality control issues that may compromise sterility assurance.

    Product
    Fentanyl injectable 2000 mcg/mL packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
    Category
    Distribution
    0 states